Previously, tumor cell–specific miR-142-5p expression has been shown to promote tumor immune evasion through inhibition of phosphatase tensin homolog (PTEN), leading to downstream upregulation of PD-L1, restricting CD4+ T cell antitumor immunity (61), or inducing cancer stem cell–like properties. This evidence concerns the gene CD4 and neoplasm.